Enforcement record

Cease and Desist Order disclosure naming ニューセンス有限会社

ニューセンス有限会社 (Pharmaceutical Affairs Act)

This page records one action from a Japanese government disclosure, including the published name, governing law, authority, action details, and official source.

Pharmaceutical Affairs ActMinistry of Health, Labour and WelfareGovernment disclosure7 October 2013

Action type

Cease and Desist Order

Law

Pharmaceutical Affairs Act

Authority

Ministry of Health, Labour and Welfare

Action date

7 October 2013

Current page: Enforcement record

This screen focuses on one disclosed action: the published name, governing law, authority, facts, source status, and review evidence.

Source verification

Public-source and preservation status

Publishing authority
Ministry of Health, Labour and Welfare
Official source URL
Recorded by RegBase
Entity match
Not confirmed; shown under the published name
Kiroku preservation
Queued for preservation
Captured: Jul 12, 2026, 03:13 PM JST

“Confirmed” means that RegBase matched this record to the cited public disclosure or entity under the stated checks. It does not verify the truth of the disclosure or guarantee the entity’s current status, creditworthiness, or any legal conclusion.

Available sources and saved files are listed in the public documents section below.

Public documents and saved materials

View the original publications, see what was preserved, or download each file below.

Loading materials…

Action summary

Company
ニューセンス有限会社Japanese only
Original: ニューセンス有限会社
Governing law
Pharmaceutical Affairs Act
薬事法
Action type
Cease and Desist Order
措置命令
Action date
7 October 2013
Issuing authority
Ministry of Health, Labour and Welfare
厚生労働省
Industry context
医薬品販売

Violation

Machine-translated summary — verify against original

Selling pharmaceuticals without obtaining permission under the Pharmaceutical and Medical Device Act.

Show original Japanese text

薬事法の許可を得ずに医薬品を販売していた

Compliance context

Medium-high

A formal administrative corrective order requiring remedial measures under the cited law.

Japanese regulatory disclosure under Pharmaceutical Affairs Act.

Check the official source for the exact conduct, corrective obligations, and whether similar marketing or sales practices continue.

This context is an operational aid for review workflows, not a credit opinion or legal conclusion.

About this recordAggregated and translated from public Japanese government disclosures. The English text is for reference only — authoritative content is the linked Japanese source.